GEMCYTABIN (CYTOGEM®) AND CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED BLADDER CANCER:  RESULTS OF A PROSPECTIVE OPEN-LABELED NON-COMPARATIVE NON-RANDOMIZED STUDY

V. B. Matveev; M. I. Volkova; M. M. Konstantinova; L. V. Schapligin; G. M. Manikhas

For citations:

Matveev V.B., Volkova M.I., Konstantinova M.M., Schapligin L.V., Manikhas G.M. GEMCYTABIN (CYTOGEM®) AND CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED BLADDER CANCER: RESULTS OF A PROSPECTIVE OPEN-LABELED NON-COMPARATIVE NON-RANDOMIZED STUDY. Cancer Urology. 2009;5(4):46-49. (In Russ.) https://doi.org/10.17650/1726-9776-2009-5-4-46-49

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Cancer Urology

For citations:

Cookies policy